ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral markerPatrícia Regina Manzine, Márcia R. Cominetti, Jordi Olloquequi et al.|Biomedicine & Pharmacotherapy|2019Cited by 83
Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 MiceMiren Ettcheto, Antoni Camins, Amanda Cano et al.|Molecular Neurobiology|2019Cited by 73
Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease DementiaMiren Ettcheto, Antoni Camins, Jordi Olloquequi et al.|Frontiers in Aging Neuroscience|2020Cited by 73
The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s DementiaJaume Folch, Antoni Camins, Mònica Bulló et al.|Frontiers in Aging Neuroscience|2019Cited by 71
Significant increase of CD57<sup>+</sup>cells in pulmonary lymphoid follicles of COPD patientsJordi Olloquequi, J.M. Escribano Ferrer|European Respiratory Journal|2010Cited by 31